Аланинаминотрансфераза и специфические маркеры вирусных гепатитов в крови доноров
https://doi.org/10.22416/1382-4376-2018-28-1-50-54
Аннотация
Об авторах
Ж. К. БуркитбаевРоссия
Г. А. Есенбаева
Россия
С. А. Абдрахманова
Россия
Ж. Ж. Бибеков
Россия
Е. Б. Жибурт
Россия
Список литературы
1. Zhiburt E.B., Belgesov N.V., Vaschenko T.N. et al. Alanine aminotransferase is a surrogate marker of viral hepatitis. Vopr virusol 1995; 1(40):25-7.
2. Zhiburt E.B. Study design «The Importance of Screening of Alanine Aminotransferase in donors blood for the Prevention of Post-Transfusion Hepatitis». Transfusiology 2004; 1(5):90-7.
3. Zhiburt E.B. About ALT and not only. Transfusiology 2004; 1(5):102-6.
4. Zhiburt E.B., Abzhueva O.V., Atakishiev M.M. et al. Significance of activity of alanine aminotransferase as a surrogate marker of transfusion-transmitted infections - the results of a national study. Vestnik Sluzby Krovi Rossii 2005; 2:22-7.
5. Zhiburt E.B. Alanine aminotransferase is a surrogate marker of viral hepatitis. Vopr virusol 2005; 6(50):18-20.
6. Zhiburt E.B., Kodenev A.T. Preliminary screening of alanine aminotransferase activity increases the economic efficiency of blood production. Klin labor diagnost 2009; 11:14-6.
7. Golosova S.A., Cherkasov E.G., Popova V.I. et al. Donors blood with increased ALT activity, but with a negative EIA result for viral hepatitis, does not contain these viruses. Top issues hematol transfusiol 2004; 118-9.
8. Filina N.G., Kolotvina T.B., Titova S.A., Zhiburt E.B. Diagnostic significance of alaninaminotransferase detection in donors blood. Transfusiology 2011; 1(12):9-12.
9. Filina N.G., Kolotvina T.B., Titova S.A., Zhiburt E.B. Preliminary screening of blood donor alaninaminotransferase activity has been lost its economical efficacy. Transfusiology 2011; 3(12):61-4.
10. Petrik J., Lozano M., Seed C.R. et al. Hepatitis E. Vox Sang 2016; 1(110):93-103.
11. Tereshchenko Y.A., Tereshchenko S.Y. Asymptomatic increase in serum aminotransferase activity: stages of diagnostic search. Ross z gastroenterol gepatol koloproktol 2014; 1(24):29-38.
12. Приказ и.о. Министра здравоохранения Республики Казахстан от 10 ноября 2009 года № 684 «Об утверждении Правил контроля качества и безопасности донорской крови и ее компонентов».
13. Abdrakhmanova S. The pattern of donor blood rejection after implementation of pre-donation liver transferase screening. Vox Sang 2016; 111(Suppl. 1):149-50.
14. Rommel K., Koch C.D., Spilker D. Influence of specimen withdrawal on the results of chemical analyses of blood, plasma and serum in patients with stable or centralized circulation. J Clin Chem Clin Biochem 1978; 16(7):37380.
15. Haymond R.E., Knight J.A. Venous serum, capillary serum, and capillary plasma compared for use in determination of lactate dehydrogenase and aspartate aminotransferase activities. Clin Chem 1975; 21(7):896-7.
16. Solanki A., Singh A., Chaudhary R. Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India. AJTS 2016; 10(1):71-4.
17. Alter M.J., Kuhnert W.L., Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003; 52(RR-3):1-13, 15; quiz CE1-4.
18. Ivashkin V.T., Herman E.N., Maevskaya M.V. Hidden infection with hepatitis B virus. Ross z gastroenterol gepatol koloproktol 2008; 2(18):4-11.
Рецензия
Для цитирования:
Буркитбаев Ж.К., Есенбаева Г.А., Абдрахманова С.А., Бибеков Ж.Ж., Жибурт Е.Б. Аланинаминотрансфераза и специфические маркеры вирусных гепатитов в крови доноров. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(1):50-54. https://doi.org/10.22416/1382-4376-2018-28-1-50-54
For citation:
Burkitbayev Zh.K., Yesenbayeva G.A., Abdrakhmanova S.A., Bibekov Zh.Zh., Zhiburt Ye.B. Alaninaminotransferase and specific viral hepatitis markers in the blood of donors. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):50-54. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-1-50-54
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.